Baskal, S.; Tsikas, S.A.; Begou, O.; Bollenbach, A.; Lenzen, S.; Jörns, A.; Tsikas, D.
Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes. Int. J. Mol. Sci. 2022, 23, 1541.
https://doi.org/10.3390/ijms23031541
AMA Style
Baskal S, Tsikas SA, Begou O, Bollenbach A, Lenzen S, Jörns A, Tsikas D.
Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes. International Journal of Molecular Sciences. 2022; 23(3):1541.
https://doi.org/10.3390/ijms23031541
Chicago/Turabian Style
Baskal, Svetlana, Stefanos A. Tsikas, Olga Begou, Alexander Bollenbach, Sigurd Lenzen, Anne Jörns, and Dimitrios Tsikas.
2022. "Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes" International Journal of Molecular Sciences 23, no. 3: 1541.
https://doi.org/10.3390/ijms23031541
APA Style
Baskal, S., Tsikas, S. A., Begou, O., Bollenbach, A., Lenzen, S., Jörns, A., & Tsikas, D.
(2022). Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes. International Journal of Molecular Sciences, 23(3), 1541.
https://doi.org/10.3390/ijms23031541